First Time Loading...

Tibet Rhodiola Pharmaceutical Holding Co
SSE:600211

Watchlist Manager
Tibet Rhodiola Pharmaceutical Holding Co Logo
Tibet Rhodiola Pharmaceutical Holding Co
SSE:600211
Watchlist
Price: 46.35 CNY -2.11%
Updated: Apr 29, 2024

Tibet Rhodiola Pharmaceutical Holding Co
Cash from Investing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Tibet Rhodiola Pharmaceutical Holding Co
Cash from Investing Activities Peer Comparison

Comparables:
1099
S
601607
600998
C
600511
000963

Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Investing Activities CAGR 3Y CAGR 5Y CAGR 10Y
Tibet Rhodiola Pharmaceutical Holding Co
SSE:600211
Cash from Investing Activities
-¥831.9m
CAGR 3-Years
N/A
CAGR 5-Years
-126%
CAGR 10-Years
-39%
Sinopharm Group Co Ltd
HKEX:1099
Cash from Investing Activities
-¥2.8B
CAGR 3-Years
14%
CAGR 5-Years
11%
CAGR 10-Years
1%
S
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
Cash from Investing Activities
-¥2.5B
CAGR 3-Years
-13%
CAGR 5-Years
20%
CAGR 10-Years
-11%
Jointown Pharmaceutical Group Co Ltd
SSE:600998
Cash from Investing Activities
-¥1.5B
CAGR 3-Years
-4%
CAGR 5-Years
7%
CAGR 10-Years
-11%
C
China National Medicines Corp Ltd
SSE:600511
Cash from Investing Activities
-¥129.3m
CAGR 3-Years
-32%
CAGR 5-Years
8%
CAGR 10-Years
-1%
Huadong Medicine Co Ltd
SZSE:000963
Cash from Investing Activities
-¥1.2B
CAGR 3-Years
4%
CAGR 5-Years
13%
CAGR 10-Years
-17%

See Also

What is Tibet Rhodiola Pharmaceutical Holding Co's Cash from Investing Activities?
Cash from Investing Activities
-831.9m CNY

Based on the financial report for Dec 31, 2023, Tibet Rhodiola Pharmaceutical Holding Co's Cash from Investing Activities amounts to -831.9m CNY.

What is Tibet Rhodiola Pharmaceutical Holding Co's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 10Y
-39%

Over the last year, the Cash from Investing Activities growth was -48%.